Table 4.
Baseline | |||||||||
---|---|---|---|---|---|---|---|---|---|
CD4+ | HLADR+ CD4+ | PD1+ CD4+ | HLADR+ PD1+ CD4+ | CD8+ | HLADR+ CD8+ | PD1+ CD8+ | HLADR+ PD1+ CD8+ | CD4:CD8 Ratio | |
FACT | 0.11 | −0.10 | −0.04 | −0.22 | −0.32 | −0.17 | 0.02 | −0.18 | 0.29 |
Fatigue | (0.46) | (0.52) | (0.77) | (0.14) | (0.03)* | (0.25) | (0.92) | (0.21) | (0.05) |
6min Walk | −0.16 | 0.11 | −0.28 | −0.06 | 0.05 | 0.10 | −0.31 | −0.15 | −0.13 |
Test (m) | (0.28) | (0.46) | (0.05) | (0.69) | (0.73) | (0.49) | (0.03)* | (0.32) | (0.37) |
Eight Foot | |||||||||
0.01 | −0.04 | 0.37 | 0.13 | 0.07 | 0.06 | 0.27 | 0.30 | −0.01 | |
Timed Up | |||||||||
(0.92) | (0.80) | (0.01)* | (0.37) | (0.66) | (0.69) | (0.07) | (0.04)* | (0.92) | |
&Go (sec) | |||||||||
Grip | |||||||||
0.15 | 0.34 | −0.20 | 0.27 | −0.18 | 0.22 | −0.10 | −0.02 | 0.13 | |
Strength | |||||||||
0.30) | (0.02)* | (0.18) | (0.07) | (0.23) | (0.14) | (0.49) | (0.92) | (0.37) | |
(kg) | |||||||||
16-weeks | |||||||||
CD4+ | HLADR+ CD4+ | PD1+ CD4+ | HLADR+ PD1+ CD4+ | CD8+ | HLADR+ CD8+ | PD1+ CD8+ | HLADR+ PD1+ CD8+ | CD4:CD8 Ratio | |
6min Walk | −0.07 | 0.15 | −0.34 | 0.10 | 0.02 | 0.20 | −0.25 | −0.05 | −0.12 |
Test (m) | (0.66) | (0.3) | (0.02)* | (0.49) | (0.88) | (0.17) | (0.09) | (0.73) | (0.43) |
30sec Arm | |||||||||
0.05 | 0.01 | −0.38 | −0.09 | 0.05 | 0.15 | −0.22 | −0.07 | 0.02 | |
Curl R | |||||||||
(0.75) | (0.94) | (0.01)* | (0.53) | (0.83) | (0.33) | (0.14) | (0.64) | (0.90) | |
(reps) | |||||||||
30sec Arm | |||||||||
0.09 | −0.04 | −0.30 | −0.14 | 0.01 | 0.14 | −0.12 | −0.01 | 0.00 | |
Curl L | |||||||||
(0.55) | (0.80) | (0.04)* | (0.34) | (0.96) | (0.34) | (0.43) | (0.96) | (1.00) | |
(reps) |
indicates significant correlation (p<0.05) (2-tail).
FACT: Functional Assessment of Cancer Therapy, L: left, R: right